Carbazole inhibitors of Cox-2

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548443, 548444, 548447, 548449, A61K 3140, C07D20982

Patent

active

058246991

ABSTRACT:
This invention provides compounds of formula I having the structure ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are, each, independently, hydrogen, alkyl, alkenyl, alkynyl, alkoxy, aralkoxy, trifluroalkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, cyano, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido;

REFERENCES:
patent: 4686213 (1987-08-01), Ferdinandi et al.
patent: 4927842 (1990-05-01), Mobilio
Humber et al., Etodolac, a Novel Antiiinflammatory Agent. The Synthesis and Biological Evaluation of Its Metabolites 1988, 31:1712-1719; J. Med. Chem.
Lewis and Kreft, A Review on the Strategies for the Development and Application of New Anti-arthritic Agents, Immunopharmacol. Immunotoxicol., 1995, 17:607-663.
Marcus, Aspirin as Prophalaxis Against Colorectal Cancer, New. Eng. J. Med., 1995, 333:656-657.
Vane et al., The mode of action of anti-inflammatroy drugs, Postgrad. Med. J., 1990, 66(Suppl 4):S2-S17.
Brooks et al., Nonsteroidal Antiinflammatory Drug -Differences and Similarities, 1991, New Eng. J. Med., 324:1716-1725.
Dajani et al., Prevention and Treatment of Ulcers Induced by Nonsteroidal Anti-Inflammatory Drugs: An Update, 1995, J. Physiol. Pharmacol., 46:3-16.
Somasundaram et al., The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis, 1995, Scand J. Gastroenterol, 30:289-299.
Hayllar et al., NSAIDs, Cox-2 inhibitors, and the gut, 1995,Lancet, 346:521-522.
O'Neill et al., Overexpression of Human Prostaglandin G/H Synthase-1 and -2 by Recombinant Vaccina Virus: Inhibition by Nonsteroidal Anti-inflammatory Drugs and Biosynthesis of 15-Hydroxyeicosatetraenoic Acid,1994,Molec. Pharmacol.,45:245-254.
Laneuville et al., Differential Inhibition of Human Prostaglandin Endoperoxide H Synthases-1 and -2 by Nonsteroidal Anti-inflammatory Drugs, 1994, Pharamcol. Exp. Ther., 271:927-934.
Mitchell et al., Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxgenase, 1993, Proc. Natl. Acad. Sci. USA, 90:11693-11697.
Chan et al., Pharmacology of a selective Cyclooxygenase-2 Inhibitor, L-745,337: A Novel Nonsteroidal Anti-inflammatory Agent with an Ulcerogenic Sparing Effect in Rat and Nonhuman Primate Stomach, 1995, J. Pharmacol. Exp. Ther., 274:1531-1537.
Masferrer et al., Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic, 1994, Proc. Natl. Acad. Sci. USA, 91:3228-3232.
Seibert et al., Pharmacological and biochemical demonstration of the role of cyclo oxygenase 2 in inflammation and pain, 1994, Proc. Natl. Acad. Sci. USA, 91:12013-12017.
Glaser et al.,Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1, 1995, Eur. J. Pharmacol., 281:107-111.
Sano et al., Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer, 1995, Cancer Res., 55:3785-3789.
Rogers et al., Clinical trial of indomethacin in Alzheimer's disease, 1993, Neurology, 43:1609-1611.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Carbazole inhibitors of Cox-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carbazole inhibitors of Cox-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbazole inhibitors of Cox-2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-244772

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.